Hotwire Ignite Possibility Program Introduces the First Group of Tech-enabled DEI Innovators
30.6.2021 16:00:00 EEST | Business Wire | Press release
Hotwire, the leading global technology communications consultancy part of Enero Group, has announced the first set of participating companies in the Hotwire Ignite Possibility Program (HIPP). Launched earlier this year, HIPP is providing $1 million USD in pro bono brand marketing and public relations services to tech and tech-enabled organizations led by or supporting minority communities. This program is part of Hotwire’s Diversity, Equity, and Inclusion (DEI) strategy to amplify people and organizations creating meaningful and sustainable change in the world through technology innovation.
After a rigorous review process of nearly 100 applicants, including in-depth interviews with a short list of finalists, the first group of participating companies includes for-profit and nonprofit organizations in the consumer and B2B technology industries with headquarters in the United States and United Kingdom. HIPP participants from our other European offices and Australia will be announced in the coming months.
The six initial participating companies are:
- Children’s Creativity Musuem , a nonprofit organization offering hands-on, multimedia arts and technology experiences to build children’s creative confidence.
- Full Circle Fund , a nonprofit community leveraging professionals’ financial and intellectual capital to accelerate nonprofits and build a better San Francisco Bay Area.
- Go Flyy , an on-demand, same-day delivery and returns service for fashion, beauty and wellness products, currently operating in Los Angeles, New York City and Seattle.
- Husmus , an online service that aims to make renting easy and affordable in order to build a world where everyone can enjoy renting privately.
- Menther , a digital platform helping to empower and advance women globally through cross and intra-generational mentorship matching and support.
- Storyskimo , an online platform leveraging audio and podcasting as a language and learning development tool for children.
Additionally, as part of HIPP, our Spain office has launched an industry collaborative think tank, Margarita Bly , that is working to pave the way for more female communicators of science, technology and innovation, and encourage more girls and young women to pursue STEM careers.
“We are thrilled to announce the first class of participants in the Hotwire Ignite Possibility Program and look forward to supporting the communications goals of this impressive group of companies,” said Heather Kernahan, Global CEO, Hotwire. “This program is a critical part of Hotwire’s Diversity, Equity, and Inclusion (DEI) strategy to direct more of our resources towards the advancement of social justice in our industry.”
Teams from Hotwire’s global offices will be working with the selected organizations to address their specific business needs through customized programs that include brand strategy, marketing, and public relations services.
“We are honored to be selected as a HIPP participant and so excited to work with a world-class technology communications agency like Hotwire. Children’s Creativity Museum’s mission to nurture creativity and collaboration in all children and families, specifically those in socially and economically disadvantaged communities, is well-aligned with the program goals,” said Carol M. Tang, Ph.D., Executive Director, Children’s Creativity Museum. “We can’t wait to get started.”
“As a female minority co-founder who benefited from mentorship early on in my own career, I’m thrilled to be working with Hotwire to help us scale Menther so more women can have easy access to the power of mentorship,” said Vanessa Villaverde, Menther. “We know this partnership is going to be game changing for us in our reach and impact at a time when women who have been economically impacted by COVID-19 need support the most,” Menther Co-Founder Lesli Ott said.
“We truly believe that no matter who you are or what background you come from, you should be able to access safe and secure housing without having to worry about your credit history or the upfront costs involved,” said Sarah Wernér, Founder of Husmus. “The team and I have worked really hard to create a product that solves a big problem. However, we recognise while we have great technical experience, we do not have the marketing skills to make sure that we are able to reach the many people who need us. Working with Hotwire gives us access to expertise that we otherwise would not have at this early stage and we can’t wait to kick things off,” Husmus’ founder Sarah Wernér said.
About Hotwire
Hotwire is the global technology communication consultancy, part of the Enero Group. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation. www.hotwireglobal.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005248/en/
Contact information
Kelsey Quickstad
kelsey.quickstad@hotwireglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
